—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Virbac SA (VIRP.PA) — the peer cohort

As of 2026-10-06 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Virbac SA ranks 10 of 11 in its cohort on the Closelooknet composite (48/100) — the cohort is led by BB Biotech AG at 73/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
VIRP.PA Virbac SA 48 31 54 63 warn 19.5%
LLY Eli Lilly and Company 64 63 92 30 watch 11.6%
ORNAV.HE Orion Oyj A 62 78 85 34 ok 3.4%
ORNBV.HE Orion Oyj B 62 77 85 34 ok 3.8%
AMGN Amgen Inc 55 72 86 41 watch 9.9%
NVO Novo Nordisk A/S 54 23 87 74 bear 39.3%
EL.PA EssilorLuxottica S. A. 45 7 49 59 bear 54.3%
BION.SW BB Biotech AG 73 59 96 81 info 12.9%
DXCM DexCom Inc 65 78 81 37 bull 6.1%
ANN.AU Ansell Ltd 64 93 49 53 ok 0.9%
ONC BeiGene, Ltd. 64 78 66 32 ok 5.8%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-06

Quick answers

Who are Virbac SA's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Orion Oyj B (ORNBV.HE), Amgen Inc (AMGN), Novo Nordisk A/S (NVO), EssilorLuxottica S. A. (EL.PA), BB Biotech AG (BION.SW), DexCom Inc (DXCM) and others.

How does VIRP.PA score against its peers?

Virbac SA's composite reads 48/100, ranking 10 of 11 in its cohort as of 2026-10-06; the cohort's highest composite is BB Biotech AG at 73/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.